Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection
about
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza InfectionsAssays for monitoring susceptibility of influenza viruses to neuraminidase inhibitorsNeuraminidase inhibitors for influenza B virus infection: efficacy and resistanceSafety and efficacy of peramivir for influenza treatmentPeramivir injection in the treatment of acute influenza: a review of the literatureUse of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09Two years after pandemic influenza A/2009/H1N1: what have we learned?Japanese Surveillance Systems and Treatment for Influenza.Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyA cutting-edge view on the current state of antiviral drug development.Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria.Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variantsEfficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experimentPharmacokinetics of Peramivir in an Adolescent Patient Receiving Continuous Venovenous Hemodiafiltration.A review of neuraminidase inhibitor susceptibility in influenza strains.Peramivir: an intravenous neuraminidase inhibitor.Antiviral therapy for respiratory viral infections in immunocompromised patients.Molecular docking, synthesis, and biological evaluation of naphthoquinone as potential novel scaffold for H5N1 neuraminidase inhibition.A rapid LC-MS/MS quantification of peramivir using a simple and inexpensive sample precipitation: application to PK.Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers.Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac
P2860
Q26749578-E558E0E4-C59E-47C8-84F3-FD0254ED58A9Q27013442-F50807FD-4840-43E7-AEF7-F474BB5F9729Q27021579-50C8351D-1E2F-4A39-A28C-74207DE95443Q27027408-00A73EA4-5E09-42A7-8EA0-EACE7CEF016EQ28068310-476433DB-F1BE-481E-BCD2-801A13D86FDBQ28480880-0D85DEEE-5BFD-4185-947A-1E4B88DF714FQ30224656-EF4A3AF7-0F7A-406E-AE0D-AE635C9E0D41Q30239895-7F569801-09E4-4628-8DCB-FC9663C62BD5Q30364319-B450AE88-E8E9-4B3A-9D70-611420C987A9Q30415224-8152CA92-077E-4A7B-91C6-6D45D009E592Q33827819-80C0A835-A84E-4792-A658-A17255961E29Q34036018-5B54DC0D-07C9-49EA-B377-346437E092B3Q34058036-454E9CAB-0C51-44EC-BC20-15DA5BDB341DQ34292717-C16EAB30-A7A7-4953-A05D-C029BE5E9936Q35076812-02F0E440-C46C-4765-B4A2-61F29C5B1ED8Q36071934-E5FECA5E-5FA7-4D7E-8909-EDD9BE8BDA37Q37686604-E7DC7BD4-BA1D-440D-B749-3ACD6A0BC958Q38258646-B54D87F1-B3F4-46AB-8205-3476A159A42AQ38543777-3D65CCFF-81BF-44AB-AEFB-A4AE98A0A0A6Q39076394-6C3775DD-8FCE-46C9-9F85-9293C7816280Q40408390-C38F1DF2-EE89-429E-9FF5-4E862D2B7863Q41474937-C971F55F-9FF7-4045-B345-B463FBE2A0A4Q42200492-916513D0-4F77-47F5-A249-B041BB080F3DQ43168383-CE881A94-DE51-41F6-B9A1-FCC0F1EF1599Q45947329-54609B62-39CF-47AF-B1F9-0D695FFAE8B6Q56974770-EFD0C64A-A95D-4C56-BD40-BCCF921DDA1C
P2860
Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy, safety, and pharmaco ...... N1 influenza A virus infection
@ast
Efficacy, safety, and pharmaco ...... N1 influenza A virus infection
@en
type
label
Efficacy, safety, and pharmaco ...... N1 influenza A virus infection
@ast
Efficacy, safety, and pharmaco ...... N1 influenza A virus infection
@en
prefLabel
Efficacy, safety, and pharmaco ...... N1 influenza A virus infection
@ast
Efficacy, safety, and pharmaco ...... N1 influenza A virus infection
@en
P2093
P2860
P356
P1476
Efficacy, safety, and pharmaco ...... N1 influenza A virus infection
@en
P2093
Norio Sugaya
Shigeru Kohno
Takao Takahashi
Toru Ishibashi
Toshihiro Wajima
P2860
P304
P356
10.1128/AAC.00132-11
P407
P577
2011-10-24T00:00:00Z